Tissue‐Engineered Cochlear Fibrosis Model Links Complex Impedance to Fibrosis Formation for Cochlear Implant Patients
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Simone R de Rijk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Hearing Group, Cambridge, CB2 8AF, UK. Hauptthemen laut MEDLINE: Cochlear Implants, Cochlear Implantation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, Wellcome Trust.
Abstract (Originalsprache)
Cochlear implants are a life‐changing technology for those with severe sensorineural hearing loss, partially restoring hearing through direct electrical stimulation of the auditory nerve. However, they are known to elicit an immune response resulting in fibrotic tissue formation in the cochlea that is linked to residual hearing loss and suboptimal outcomes. Intracochlear fibrosis is difficult to track without postmortem histology, and no specific electrical marker for fibrosis exists. In this study, a tissue‐engineered model of cochlear fibrosis is developed following implant placement to examine the electrical characteristics associated with fibrotic tissue formation around electrodes. The model is characterized using electrochemical impedance spectroscopy and an increase in the resistance and a decrease in capacitance of the tissue using a representative circuit are found. This result informs a new marker of fibrosis progression over time that is extractable from voltage waveform responses, which can be directly measured in cochlear implant patients. This marker is tested in a small sample size of recently implanted cochlear implant patients, showing a significant increase over two postoperative timepoints. Using this system, complex impedance is demonstrated as a marker of fibrosis progression that is directly measurable from cochlear implants to enable real‐time tracking of fibrosis formation in patients, creating opportunities for earlier treatment intervention to improve cochlear implant efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cambridge Hearing Group, Cambridge, CB2 8AF, UK.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 3 EB, UK.
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, UK.
- Department of Electronic Engineering, Tsinghua University, Beijing, 100190, P. R. China.
- Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
ORCID-Profile: Simone R de Rijk, Alexander J Boys, Iwan V Roberts, Chen Jiang, Charlotte Garcia, Róisín M Owens, Manohar Bance
Förderung
- Medical Research Council
- Department of Health
- Wellcome Trust
- NIHR Cambridge Biomedical Research Centre
- Human Frontier Science Program
- Evelyn Trust
Zitieren
APA
de Rijk, S. R., Boys, A. J., Roberts, I. V., Jiang, C., Garcia, C., Owens, R. M., & Bance, M. (2023). Tissue‐Engineered Cochlear Fibrosis Model Links Complex Impedance to Fibrosis Formation for Cochlear Implant Patients. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300732
Vancouver
de Rijk SR, Boys AJ, Roberts IV, Jiang C, Garcia C, Owens RM, et al. Tissue‐Engineered Cochlear Fibrosis Model Links Complex Impedance to Fibrosis Formation for Cochlear Implant Patients. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300732
BibTeX
@article{deRijk2023,
author = {de Rijk, Simone R and Boys, Alexander J and Roberts, Iwan V and Jiang, Chen and Garcia, Charlotte and Owens, Róisín M and Bance, Manohar},
title = {Tissue‐Engineered Cochlear Fibrosis Model Links Complex Impedance to Fibrosis Formation for Cochlear Implant Patients},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300732}
}
EUVIMED